Biosimilars – SRK Analytics

Indian Pharma Sector Pivots as US Evaluates Steep Tariffs on Generic Drug Imports

Discover how Indian drugmakers are adapting to potential US tariffs on generic imports while maintaining their global lead in affordable healthcare.

Prasenjit Bhowmik July 24, 2026

Market

Cipla’s Strategic Outlook: Navigating Growth in the Global Pharmaceutical Landscape

As global demand for affordable healthcare continues to escalate, Mumbai-based pharmaceutical giant Cipla Limited is positioning itself for a pivotal three-year growth trajectory. With rising exports and a robust pipeline…

Prasenjit Bhowmik July 3, 2026